According to The Insight Partners market research study of “Exosome Diagnostic and Therapeutic Market Forecast to 2027 – Covid-19 Impact and Global Analysis by Application, Product, and End User,” the global exosome diagnostic and therapeutic market is projected to reach US$ 358.91 million by2027 from US$ 41.6.33 million in2019. The market is estimated to grow at a CAGR of 32.2% from 2020 to 2027. The report highlights trends prevailing in the global exosome diagnostic and therapeutic market and the factors driving market along with those that act as hindrances.
(**Note: The sample of this report is updated with COVID-19 impact analysis**)
To Know How COVID-19 Pandemic Will Impact Global Exosome Diagnostics and Treatment Market | Get a Sample Copy of Report, Click Here: https://www.theinsightpartners.com/sample/TIPRE00005514/
The global exosome diagnostic and therapeutic market, based on application, is further segmented into diagnostic and therapeutic. The diagnostic segment held a larger share of the market in 2019. Also, the diagnostic segment is estimated to register a higher CAGR during the forecast period owing to increasing adoption to exosomes for the diagnosis of chronic conditions and increasing awareness of procedural outcomes served by exosomes. Increasing awareness about exosomes diagnostics is propelling the companies to enter into this market to tap lucrative opportunities. For instance, in March 2016, Sysmex and JVCKENWOOD launched a joint program for the development of diagnostic instruments for measurement of exosomes.
The exosome diagnostic and therapeutic market is expected to grow owing to factors such as greater precision and advantages over traditional methods of diagnosis and therapeutics and increasing number of research activities in the field of exosomes. However, poor infrastructure and lack of expertise required for isolation of exosomes are likely to restrain the growth of the market during the forecast period.
Leading companies operating in the exosome diagnostic and therapeutic market are Aethlon Medical, Inc., Therapeutic Solutions International, Inc., ReNeuron Group plc, Immune Therapy Holdings AB, Cell Guidance Systems LLC, BioRegenerative Sciences, Evomic Science LLC, NorgenBiotek Corp., Exosome Diagnostics, Inc./Bio-Techne, and MiltenyiBiotec, among others.
Greater Precision and Advantages over Traditional Methods of Diagnosis and Therapeutics
Exosomes are distinct populations of tiny membranous vesicles, released into the extracellular space by most cells, which get eventually accumulated in the body fluid circulation. By acting as cellular messengers, they play a role in vital physiological functions by transporting information between different cell types. These tiny particles carry cellular nucleic acids and proteins from their host cells to target cells, which represent the comprehensive information about pathophysiological conditions of the host cell. For instance, exosomes released from tumor cells contains tumor-specific RNAs that can be potentially detected during cancer diagnosis. These carrier exosomes can also be used as biomarkers in the diagnosis of neurodegenerative and metabolic disorders, and infectious and other diseases. Additionally, the presence of exosomes in body fluids such as saliva and urine islikely to rule out the traditional methods involving the collection of the invasive body fluids.Thus, the growing emphasis on clinically noninvasive diagnosis is likely to drive the adoption of exosomes-based diagnosis and therapeutics in the medical industry during the forecast period.
Based on application, the exosome diagnostic and therapeutic market is further segmented into diagnostic applications and therapeutic applications. The diagnostic applications segment held a larger share of the market in 2019owing to increasing awareness of the procedural outcomes served by exosomes. For instance, in March 2016, Sysmex and JVCKENWOOD launched a joint program for the development of diagnostic instruments for measurement of exosomes. Also, the diagnostic segment is expected to register ahigher CAGR in the market during the forecast period. Apart from this, exosomes are emerging as promising therapeutic platforms due to its role in disease prorogation. Such involvement of exosomes can allow us to inhibit the disease progression with the help of targeted drug therapy.
The exosome diagnostic and therapeuticmarket, by product, is sub segmented into instruments, reagents, and software.In 2019, the instrument segment accounted for the largest share of the global exosome diagnostic and therapeuticmarket owing to increasing adoption of instruments for diagnostic applications. However, the software segment is estimated to register the highest CAGR in the market during the forecast period. This can be attributed to the demand for technological platforms offering data integrity, access, and security for collected data in exosome diagnostic and therapeutic applications.
The exosome diagnostic and therapeutic market, by end user, is further segmented into cancer institute, hospitals, diagnostic centers, and others. The cancer institute segment held the largest share of the market in 2019 owing to increasing cancer cases and demand for advanced diagnostic approaches. Cancer instituteare specifically dedicated for the cancer research, drug development, and study on cancer management. The efficiency of exosomes in the diagnosis of cancer is projected to drive the growth of the cancer institute segment during the forecast period.
Product launches and expansion strategy is commonly adopted by companies to expand their footprint worldwide and meet the growing demand. This strategy is most commonly adopted by the market players in order to expand its product portfolio.
The market players operating in the exosome diagnostic and therapeuticmarketadopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.
Exosome Diagnostic and Therapeutic Market – ByApplication
Exosome Diagnostic and Therapeutic Market – By Product
Exosome Diagnostic and Therapeutic Market – By End User
Exosome Diagnostic and Therapeutic Market– By Geography
Purchase a copy of the Global Exosome Diagnostics and Treatment Market report https://www.theinsightpartners.com/buy/TIPRE00005514/